Learn about financial terms, types of investments, trading strategies and more. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock. The price has fallen in 6 of the last 10 days and is down by -17.89% for this period. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Aquestive Therapeutics to $15 from $13 and reiterates a Buy rating on the shares. Find the latest Aquestive Therapeutics, Inc. (AQST) stock discussion in Yahoo Finance's forum. Close price at the end of the last trading day (Friday, 19th Feb 2021) of the AQST stock was $5.65. The price has risen in 6 of the last 10 days, but is still down by … Just click the link The number of analysts covering the stock of AQST is greater than 77.82% of stocks in the small market cap category. Their average twelve-month price target is $15.67, predicting that the stock has a possible upside of 242.07%. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Find real-time AQST - Aquestive Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The technical evaluation for the stock shows the PEG ratio is 0, with AQST’s current price about -6.53% and -18.7% off the 20-day and 50-day simple moving averages respectively. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The chart below shows how a company's share price and consensus price target have changed over time. Previously, the target price had yet another raise to $23, while RBC Capital Mkts analysts kept a Outperform rating on AQST stock. The average price target represents a 402.18% increase from the last price of $4.58. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services With a 5-year investment, the revenue is expected to be around +172.87%. The Aquestive Therapeutics Inc. stock price gained 4.63% on the last trading day (Friday, 19th Feb 2021), rising from $5.40 to $5.65. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The high price target for AQST is $33.00 and the low price target for AQST is $7.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy.". The extremes give us $7 and $32 for target low and target high price respectively. Receive a free world-class investing education from MarketBeat. AQST Stock Gets Analyst Price Target Hike. May 22, 2020. Get daily stock ideas top-performing Wall Street analysts. Aquestive Therapeutics Inc's stock had its IPO on July 25, 2018, making it an older stock than merely 6.53% of US equities in our set. Price Target Detailed list of analyst forecasts All 'A' Rated Buy Stocks, • 2 Renewable Energy Stocks to Add to Your Watchlist, • Why I Believe Gold Will Rally, and 3 Stocks That Stand to Benefit the Most, • Cybersecurity Industry in 2021: The Complete Investors Guide, • How to Ride the 2021 Stock Market Bubble. 5 analysts have issued 12-month target prices for Aquestive Therapeutics' shares. Price target in 14 days: 6.212 USD. During the day the stock fluctuated 7.01% from a day low at $5.42 to a day high of $5.80. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Stock analysis for Aquestive Therapeutics Inc (AQST:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aquestive Therapeutics Stock Forecast, AQST stock price prediction. Ratings...FREE! In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. To see all exchange delays and terms of use please see disclaimer. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Join. During the day the stock fluctuated 3.53% from a day low at $5.38 to a day high of $5.57. According to 6 analysts, the average rating for AQST stock is "Buy." Do Not Sell My Information. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Fundamental company data provided by Zacks Investment Research. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Identify stocks that meet your criteria using seven unique stock screeners. According to . risk over market), and overall volatility. The Aquestive Therapeutics Inc. stock price gained 4.08% on the last trading day (Wednesday, 24th Feb 2021), rising from $5.27 to $5.49. above. This suggests a possible upside of 196.2% from the stock's current price. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Learn everything you need to know about successful options trading with this three-part video course. Your current $100 investment may be up to $272.87 in 2026. Is AQST a Buy, Hold or Sell? 5 Wall Street analysts have issued ratings and price targets for Aquestive Therapeutics in the last 12 months. A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. ET by Tomi Kilgore Aquestive Therapeutics shares surge 6.7% in trading debut Find real-time AQST - Aquestive Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. On average, they anticipate Aquestive Therapeutics' stock price to reach $15.67 in the next year. As of January 29th, there was short interest totalling 1,370,000 shares, a drop of 29.7% from the January 14th total of 1,950,000 shares. May 22, 2020. Analysts have been projecting $7 as a low price target for the stock while placing it at a high target of $32. © American Consumer News, LLC dba MarketBeat® 2010-2021. View today's stock price, news and analysis for Aquestive Therapeutics Inc. (AQST). There are currently 5 buy ratings for the stock, resulting in a … See The average price target represents a 11.36% increase from the last price of $4.49. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Please log in to your account or sign up in order to add this asset to your watchlist. Login It follows that stock’s current price would jump +479.71% in reaching the projected high whereas dropping to the targeted low would mean a loss of 26.81% for stock’s current value. During the day the stock fluctuated 7.01% from a day low at $5.42 to a day high of $5.80. According to 6 analysts, the average rating for AQST stock is "Buy." Aquestive Therapeutics, Inc. NASDAQ Updated Feb 24, 2021 12:58 AM AQST 5.27 0.14 (2.59%). Get Our PREMIUM Forecast Now, from ONLY $7.49! Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. View which stocks are hot on social media with MarketBeat's trending stocks report. According to . AQST - Aquestive Therapeutics Inc Stock quote - … Sign Up to See The tables below show price targets and recommendations from analysts covering Aquestive Therapeutics Inc. Over the past 71 days, AQST's average price target has gone down $0. This is 4.63% more than the trading day before Thursday, 18th Feb 2021. The 12-month stock price forecast is 15.00, which is an increase of 171.00% from the latest price. 3 Wall Street analysts that have issued a 1 year AQST price target, the average AQST price target is $17.67, with the highest AQST stock price forecast at $32.00 and the lowest AQST stock price forecast at $7.00. appreciate its future potential. 5 Wall Street analysts have issued ratings and price targets for Aquestive Therapeutics in the last 12 months. The average analyst price target of AQST is higher than 31.88% of all US stocks. Start Your Risk-Free Trial Subscription Here, Warren Buffett again encourages investors to bet on America, Biden team readies wider economic package after virus relief, The Latest: U.S. FDA approves J&J single-shot vaccine, In oil-rich Iraq, a few women buck norms, take rig site jobs, Fraud overwhelms pandemic-related unemployment programs, The Latest: At 100, Captain Tom Moore honored at funeral, J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine, Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some, Guardion Health Sciences Stock Needs to Give Investors More Than Survival, Wait For a Better Price Before Placing a Bet On Churchill Downs, 3 Small Cap Dividend Stocks with Growth Prospects, It’s Okay to Take the Over on DraftKings Stock, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, Receive Analysts' Upgrades and Downgrades Daily. Get short term trading ideas from the MarketBeat Idea Engine. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Aquestive Therapeutics, Inc. (NASDAQ:AQST) was the target of a significant drop in short interest in January. Price Target Based on 2 analysts offering 12 month price targets for Aquestive Therapeutics in the last 3 months. Generally, the target price of Aquestive depends on its intrinsic valuation, beta (i.e. The dark blue line represents the company's actual price. AQST stock received a price target hike on FDA approval of APL-130277. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. AQST has a higher average analyst price target than 31.04% of all US stocks. AQST updated stock price target summary. Aquestive Therapeutics started at outperform with $33 stock price target at Wedbush Sep. 13, 2018 at 7:22 a.m. H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Aquestive Therapeutics to $15 from $13 and reiterates a Buy rating on the shares. Based on our forecasts, a long-term increase is expected, the "AQST" stock price prognosis for 2026-02-13 is 15.376 USD. Stock price targets are often quoted in the financial news media. Based on analysts offering 12 month price targets for AQST in the last 3 months. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. To see all exchange delays and terms of use, please see disclaimer. AQST has a lower variance in analysts' estimates than 0.849999999999994% of all US stocks. The average price target is $17.75, which means analysts expect the stock to add by 226.89% over the next twelve months. The 12-month stock price forecast is 15.00, which is an increase of 171.00% from the latest price. Stay up to date with lastest Earnings Announcements for Aquestive Therapeutics, Inc. … © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Just enter your email address below. Their forecasts range from $7.00 to $33.00. The new note on the price target was released on January 03, 2019, representing the official price target for Aquestive Therapeutics Inc. stock. AQST: Aquestive Therapeutics, Inc. - Earnings Announcements. You can opt out at any time. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Aquestive Therapeutics price target lowered to $7 from $10 at Lake Street 09/28/20 RBC Capital Aquestive Therapeutics price target lowered to $7 from $8 at RBC Capital 09/28/20 BMO Capital Aquestive Therapeutics price target lowered to $13 from … Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Aquestive Therapeutics Inc's percent of analysts bearish on the stock is lower than just about 100% of all US stocks. Their average twelve-month price target is $15.67, predicting that the stock has a possible upside of 188.52%. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. … MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Export data to Excel for your own analysis. Aquestive Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 92.45% of all US stocks. Want to see which stocks are moving? AQST stock received a price target hike on FDA approval of APL-130277. AQST stock received a whopping $36 price target from Wedbush after the FDA accepted the company’s NDA. The average price target is $23.00 with a high forecast of $32.00 and a low forecast of $14.00. AQST stock traded down $0.41 during trading hours on Friday, reaching $5.40. Detailed list of analyst forecasts Share your opinion and gain insight from other stock traders and investors. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). You can unlock it all now. AQST has a higher number of analysts covering the stock than 77.91% of stocks in the small market cap category. All rights reserved. Copyright © 2021. Stocks similar to Aquestive Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DMAC, AGTC and ACHV. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing. Post-Market 0.33 (6.26%) We have 9 different ratings for every stock to help you Find the latest Aquestive Therapeutics, Inc. (AQST) stock discussion in Yahoo Finance's forum. The NA of AQST is higher than just about none of of all US stocks. The Average True Range (ATR) for Aquestive Therapeutics Inc. is set at 0.40, with the Price to Sales ratio for AQST stock in the period of the last 12 months amounting to 3.61. The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. Looking for new stock ideas? Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Learn more. AQST stock received a whopping $36 price target from Wedbush after the FDA accepted the company’s NDA. See the POWR Ratings now! AQST - Aquestive Therapeutics Inc Stock quote - … 3 Wall Street analysts that have issued a 1 year AQST price target, the average AQST price target is $17.67, with the highest AQST stock price forecast at $32.00 and the lowest AQST stock price forecast at $7.00. Share your opinion and gain insight from other stock traders and investors. Based on an average daily volume of 794,700 shares, the short-interest ratio is currently 1.7 days. That average ranking earns the stock an Analyst Rating of 69, which is better than 69% of stocks based on data compiled by InvestorsObserver. Learn more. The high price target for AQST is $33.00 and the low price target for AQST is $7.00. AQST: Get the latest Aquestive Therapeutics stock price and detailed information including AQST news, historical charts and realtime prices. AQST updated stock price target summary. HC Wainwright is very positive to AQST and gave it a "Buy" rating on January 22, 2021. Previously, the target price had yet another raise to $23, while RBC Capital Mkts analysts kept a Outperform rating on AQST stock. View our full suite of financial calendars and market data tables, all for free. As such, AQST has been trading 450.77% off suggested target high and 20.48% from its likely low. AQST Stock Gets Analyst Price Target Hike. AQST Stock Summary Aquestive Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 4.47% of US listed stocks. Wall Street analysts are rating AQST a Strong Buy today. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. 921,756 shares of the stock were exchanged, compared to its average volume of 1,004,632. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The lighter blue line represents the stock's consensus price target. See what's happening in the market right now with MarketBeat's real-time news feed. Analysts on Wall Street suggest a consensus price target of $15, implying an increase of 158.18% to the stock’s current value.
Winchester Knives Set, Dirt Rally Graphics Mod, Took Her To The O Video, Slr Sr26 Muzzle Brake, In The Equation 2h2 + O2 → 2h2o, 1873 Buffalo Massacre, Gm Ls3 Crate Engine Wiring Diagram, Dt Mdr Tarkov Reddit, Mastercraft Hand Tools, Vankyo Performance V630 Review,